Milan

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Myasthenia gravis2 trials
• Amyloidosis1 trial
• High blood pressure1 trial

Phase

• Phase 31 trial

Status

• Recruiting4 trials

Lead sponsor

• Alexion Pharmaceuticals, Inc.2 trials
• Alnylam Pharmaceuticals2 trials

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

• Recruiting

  Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

  NCT06967480· Alexion Pharmaceuticals, Inc.· Source

  Contact: Alexion Pharmaceuticals, Inc. (Sponsor)

• Recruiting

  ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  NCT04561518· Alnylam Pharmaceuticals· Source

• Recruiting

  Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  NCT04202341· Alexion Pharmaceuticals, Inc.· Source

  Contact: Alexion Pharmaceuticals, Inc. (Sponsor)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis2 recruiting
• Amyloidosis1 recruiting
• High blood pressure1 recruiting